COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I FLVFLV REGNR2 LY-CoVLY RemdesivirRMD
Ivermectin study #40 of 63
12/11 Early treatment study
Hussain et al., International Journal of Molecular and Immuno Oncology, doi:10.25259/IJMIO_30_2020 (Peer Reviewed)
Outcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in Bangladesh
Source   PDF   Share   Tweet
Small case study of ivermectin + doxycycline with 8 cancer patients, with all patients becoming PCR- by day 6 when tested again.

Hussain et al., 12/11/2020, peer-reviewed, 3 authors.
Details of all 63 studies    Meta analysis
Please send us corrections, updates, or comments.